Wounds that heal and wounds that don't?The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis, Semin. Cell Dev. Biol, vol.16, pp.41-50, 2016. ,
IL-33 (interleukin 33)/SST2 (soluble suppression of tumorigenicity 2) axis in hypertension and heart failure, Hypertension, vol.72, pp.818-828, 2018. ,
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system, J. Clin. Investig, vol.117, pp.1538-1549, 2007. ,
Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques, Arterioscler. Thromb. Vasc. Biol, 2011. ,
López-Andrés, N. A role for soluble ST2 in vascular remodeling associated with obesity in rats, PLoS ONE, issue.8, p.79176, 2013. ,
Soluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts: An in vitro and in vivo study in aortic stenosis, Clin. Sci, vol.133, pp.1537-1548, 2019. ,
Soluble ST2 for Prognosis and Monitoring in Heart Failure: The New Gold Standard?, J. Am. Coll. Cardiol, vol.70, pp.2389-2392, 2017. ,
Mechanisms of Fibroblast Activation in the Remodeling Myocardium, Curr. Pathobiol. Rep, vol.5, pp.139-148, 2017. ,
Cardiac fibrosis: The fibroblast awakens, Circ. Res, vol.118, pp.1021-1040, 2016. ,
Intercellular communication lessons in heart failure, Eur. J. Heart Fail, vol.17, pp.1091-1103, 2015. ,
López-Andrés, N. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis, Clin. Sci, vol.131, pp.935-949, 2017. ,
Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model, Int. J. Mol. Sci, vol.18, p.1664, 2017. ,
Early echocardiographic predictors of outcomes in the mouse transverse aortic constriction heart failure model, J. Pharmacol. Toxicol. Methods, vol.84, pp.93-101, 2017. ,
Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding, Circ. Res, vol.73, pp.184-192, 1993. ,
Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: A new pathway to induce cardiac damage?, Clin. Sci, vol.132, pp.1471-1485, 2018. ,
A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts, Int. J. Cardiol, vol.258, pp.217-223, 2018. ,
Conflicting vascular and metabolic impact of the IL-33/sST2 axis, Cardiovasc. Res, vol.114, pp.1578-1594, 2018. ,
The IL-33/ST2 pathway: Therapeutic target and novel biomarker, Nat. Rev. Drug Discov, vol.7, pp.827-840, 2008. ,
Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells, Cell Mol. Immunol, vol.9, pp.399-409, 2012. ,
Mechanisms and models in heart failure: A combinatorial approach, Circulation, vol.100, pp.999-1008, 1999. ,
Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3, J. Am. Coll. Cardiol, vol.63, pp.158-166, 2014. ,
Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta, Carcinogenesis, vol.32, pp.613-621, 2011. ,
Neuropilins: Structure, function and role in disease, Biochem. J, vol.411, pp.211-226, 2008. ,
Neuropilin 1 modulates TGF-?1-induced epithelial-mesenchymal transition in non-small cell lung cancer, Int. J. Oncol, vol.2020, pp.531-543 ,
Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF? signaling in hepatic stellate cells, J. Clin. Investig, vol.120, pp.2379-2394, 2010. ,
Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma, Oncotarget, vol.7, pp.69489-69506, 2016. ,
Cardiac fibrosis: New insights into the pathogenesis, Int. J. Biol. Sci, vol.14, pp.1645-1657, 2018. ,
The pathogenesis of cardiac fibrosis, Cell Mol. Life Sci, vol.71, pp.549-574, 2014. ,
NF-?B-mediated integrin-linked kinase regulation in angiotensin II-induced pro-fibrotic process in cardiac fibroblasts, Life Sci, vol.107, pp.68-75, 2014. ,
Nuclear factor kappa-B and the heart, J. Am. Coll. Cardiol, vol.38, pp.307-314, 2001. ,
ST2 suppresses IL-6 production via the inhibition of I?B degradation induced by the LPS signal in THP-1 cells, Biochem. Biophys. Res. Commun, vol.341, pp.425-432, 2006. ,